June 10, 2022
The University of Cincinnati's Pier Paolo Scaglioni, MD, has received a $1.5 million National Cancer Institute grant to continue research into the roles of the KRAS gene and lipids in lung cancer.
December 8, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Hematology Annual Meeting, held Dec. 9-12 in San Diego, California.
February 15, 2024
The University of Cincinnati Cancer Center announced it is opening the Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, this summer.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
April 6, 2023
U.S. News and World Report highlighted research led by the University of Cincinnati's Jordan Kharofa that found several enriched species, associated with enhanced tumor immune response, in the microbiomes of long-term pancreatic cancer survivors.
November 27, 2023
Local 12 recently spoke with the University of Cincinnati's Andrew Waters and Pancreatic Cancer Action Network volunteers to discuss ongoing pancreatic cancer research and funding support during Pancreatic Cancer Awareness Month.
November 28, 2023
The University of Cincinnati Cancer Center's Robert Van Haren joined the Research Evangelist podcast to discuss advancements in lung cancer care and research to improve accessibility to treatments.
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.
February 29, 2024
Regional media highlighted the University of Cincinnati Cancer Center being the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.